TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05593900

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-to-Family Video Chat
Description: A Nurse-To-Family Video Chat will be offered to parents/guardians to virtually connect with their post-transfer nurse; this intervention is changing the behavior of how providers deliver healthcare and how parents/guardians engage in their child's care.
Study: NCT05373394

Intervention type: OTHER
Intervention: Test battery
Description: motor and neuropsychological test battery

Intervention type: OTHER
Intervention: Test battery
Description: motor and neuropsychological test battery
Study: NCT06189417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Extension Led club based Intervention
Description: The Health Extension Workers-led club-based intervention primarily focuses on equipping individuals with the necessary knowledge and skills to enhance their self-management behavior. The intervention encompasses education on adopting healthy eating habits, promoting regular exercise, effectively managing weight, and supporting smoking cessation. It emphasizes the importance of regular blood sugar level monitoring, limiting alcohol intake, and reducing sedentary behavior. The intervention also includes counseling to provide guidance and support in adopting and maintaining healthy behaviors. Additionally, it highlights the significance of adhering to medication regimens for optimal health outcomes. If additional medical attention is required, the intervention provides referral services to nearby health facilities.
Study: NCT04090424

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovoSorb BTM
Description: NovoSorb BTM comprises a completely synthetic, sterile, integrating dermal component (porous biodegradable polyurethane foam) and a temporary epidermal barrier component (a nonbiodegradable polyurethane sealing membrane). These layers are adhered with a biodegradable polyurethane bonding layer. BTM will be implanted and fixed into position to close a debrided burn wound. After a period of integration, the sealing membrane is removed and a split skin graft is applied.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Burn wounds will be treated using the institution's standard of care, e.g. primary skin grafting, cadaveric allograft followed by skin grafting.
Study: NCT06313099

Intervention type: OTHER
Intervention: Survey
Description: Participants' musculoskeletal system disorders were assessed using the Cornell Musculoskeletal Disorders Questionnaire (CMDQ), fatigue levels were measured using the Fatigue Severity Scale (FSS), sleep quality was evaluated using the Visual Analog Scale (VAS), depression levels were assessed using the Beck Depression Inventory (BDI), and quality of life was measured with the Nottingham Health Profile (NHP). Google Forms was used to create the data collection tools, which were then sent to the participants' email addresses and collected online.
Study: NCT05401201

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumoral treatment
Description: The investigational Lumoral treatment -device provides a constant and repeatable application which can be done at home and is easily available. All subjects in the study group will receive their own Lumoral treatment -device and Lumorinse-mouth rinse tablets for the complete duration of the study.
Study: NCT05999981

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transversalis Fascia Plane Block
Description: 40 ml %0.25 bupivacaine divided into 2 equal doses will be injected by the anesthesiologist under ultrasonography guidance between transversus abdominis muscle and transversalis fascia bilaterally

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transversus Abdominis Plane Block
Description: 40 ml %0.25 bupivacaine divided into 2 equal doses will be injected by the anesthesiologist under ultrasonography guidance in the fascial plane between internal oblique muscle and transversus abdominis muscle bilaterally
Study: NCT06440811

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOX+PD-1 antibody
Description: Patients would be allocated to the SOX+PD-1 antibody group.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FLOT+PD-1 antibody
Description: Patients would be allocated to the FLOT+PD-1 antibody group
Study: NCT05053178

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mandala activity
Description: Mindfulness-based mandala activity was applied to the intervention group via the zoom online program. Students will be divided into groups of 6-10 and mandala activities will be carried out. 3 weeks of mandala activity, breathing exercises, affirmations, etc. a therapeutic application program was created and implemented
Study: NCT05209061

Intervention type: OTHER
Intervention: Biopsy
Description: Participants included in the study, will have a full thickness biopsy of the middle of the appendix taken, after the resected bowel has been removed during surgery.
Study: NCT05035810

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Incentives and Gamification to Promote Exercise
Description: The intervention will provide social incentives and gamification to promote physical activity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Incentives and Gamification to Promote Exercise
Description: The intervention will provide social incentives and gamification to promote physical activity.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid Injection given in A-B order
Description: The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in A-B order.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid Injection given in A-B order
Description: The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in A-B order.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No Social Incentive applied
Description: No social incentive will be applied

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No Social Incentive applied
Description: No social incentive will be applied

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Procedure: Corticosteroid Injection given in B-A order
Description: The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in B-A order.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Procedure: Corticosteroid Injection given in B-A order
Description: The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in B-A order.
Study: NCT06237972

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 4-week Perturbation-based balance training
Description: Participants will be asked to walk over a six by two meters computer-controlled movable platform at a self-selected speed. Slip-like perturbations will be induced by the device software that moves the platform 12 inches forward at 0.46 m/s with an acceleration of 9.4 m/s2. Participants will be secured in a safety harness which will be attached to the overhead arch of the platform. Participants will be asked to go to the experimental study cite 11 times. A baseline screening, 8 training sessions, a post-training screening, and a 2 months folow up screening

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 4-week Perturbation-based balance training
Description: Participants will be asked to walk over a six by two meters computer-controlled movable platform at a self-selected speed. Slip-like perturbations will be induced by the device software that moves the platform 12 inches forward at 0.46 m/s with an acceleration of 9.4 m/s2. Participants will be secured in a safety harness which will be attached to the overhead arch of the platform. Participants will be asked to go to the experimental study cite 11 times. A baseline screening, 8 training sessions, a post-training screening, and a 2 months folow up screening

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Description: NMES will be applied on tibialis anterior and quadriceps muscles during perturbation-based balance training.
Study: NCT05013333

Intervention type: DEVICE
Group type: OTHER
Intervention: AED 3 with Uni-padz
Description: Use of AED 3 with Uni-padz by lay rescuer
Study: NCT02176135

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Auranofin
Description: 3 mg tablets
Study: NCT05111236

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy
Description: Rehabilitation strategies in management of children with spastic CP

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine physical therapy
Description: Rehabilitation strategies in management of children with spastic CP

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional massage
Description: Rehabilitation strategies in management of children with spastic CP
Study: NCT04392193

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton Particle Therapy
Description: Proton therapy will be delivered in a single fraction using the Probeat-V system
Study: NCT06364410

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azenosertib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azenosertib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azenosertib
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan
Description: Given IV
Study: NCT06311214

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: OTHER
Group type: OTHER
Intervention: Electronic Health Record Review
Description: Undergo review of SOC RNA testing results

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab Vedotin
Description: Given IV

Intervention type: OTHER
Group type: OTHER
Intervention: Immunohistochemistry Staining Method
Description: Undergo IHC assay

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sacituzumab Govitecan
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan
Description: Given IV
Study: NCT06125860

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Targeted BEP based on baseline nutritional status
Description: In Arm 2 (targeted BEP based on baseline nutritional status), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Targeted BEP based on baseline nutritional status and monthly GWG monitoring
Description: In Arm 3 (targeted BEP based on baseline nutritional status and monthly GWG monitoring), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm; participants with an inadequate GWG at a monthly follow-up visit will receive additional BEP supplements.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Universal BEP
Description: In Arm 4 (universal BEP), all participants will receive BEP supplements from baseline through the end of pregnancy.
Study: NCT05297565

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab/rHuPH20
Description: Specified dose on specified days

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab
Description: Specified dose on specified days
Study: NCT04992767

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sunnyside
Description: The Sunnyside intervention is an online intervention(an interactive website with didactic material and interactive tools) targeting skills to manage mood during and after pregnancy. The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Each lesson takes approximately 10 minutes to complete.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SunnysideFlex
Description: SunnysideFlex consists of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. SunnysideFlex has adapted the original Sunnyside intervention with revised, trauma-focused content that covers the impact of PTSD symptoms on the perinatal period and daily functioning, more broadly
Study: NCT05561595

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healing HEARTS
Description: Session topics will include: psychoeducation; myths and stereotypes; cognitive distortions and restructuring; coping strategies; interpersonal effectiveness; self-efficacy; mindfulness and self-compassion; acceptance and positive self-image; disclosure and finding support; stigma in health care; and empowerment and advocacy.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Peer Support
Description: Peer support groups will cover general topics such as symptom management, stress, and social support. Stigma will not be a formal topic of discussion, and group leaders will be trained to avoid initiating conversations about stigma; however, to capture realistic discussions in peer support groups, participants will not be prohibited from discussing the topic should they bring it up.
Study: NCT05283915

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tolebrutinib
Description: Pharmaceutical form: Film-coated tablet Route of administration: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tolebrutinib
Description: Pharmaceutical form: Film-coated tablet Route of administration: oral
Study: NCT05671653

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07081532
Description: Experimental oral GLP-1 drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Approved and marketed GLP-1 drug for subcutaneous injection.
Study: NCT05509322

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subsidy for fertility consult
Description: Some participants will receive a subsidy when they purchase the fertility consult.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Invitation to purchase fertility consult
Description: Some participants will receive an invitation from their health center to purchase an at-home fertility consult.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Invitation to purchase fertility consult
Description: Some participants will receive an invitation from their health center to purchase an at-home fertility consult.
Study: NCT04696562

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deep Breathing Exercise with Triflo
Description: The investigators will do deep breathing exercises 5-10 times an hour with the triflo device.
Study: NCT04350125

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Platelet Rich Plasma
Description: One 4-5mL platelet rich plasma injection administered to each side of the intracavernosal space on the right and left side of the corpus cavernosum at the base of the penis, every two weeks for 6 weeks.
Study: NCT01042353

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: E test
Description: At the time of BAL collection, a rapid antibiogram will be performed by placing E-test antibiotic strips (AB Biodisk) directly onto Mueller-Hinton agar plates seeded with the BAL specimen (both by flooding and swabbing). E-test strips will be impregnated with cefoxitin, piperacillin-tazobactam, cefepime, imipenem, ciprofloxacin and amikacin. At 24 h, the E-test plates will be photographed and then examined separately by both a bacteriologist and a medical ICU physician following a consensus method. The final E-test results will be compared with the standard MIC cultures.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard culture method
Description: BAL samples will be cultured by standard methods and the minimal inhibitory concentration (MIC) of bacteria to the usual antibiotics will be determined using standard procedures
Study: NCT06348069

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacy-based PrEP refill and gift voucher
Description: The intervention arm of this study introduces the opportunity for a pharmacy-based PrEP refill system for sex workers, coupled with financial incentives to increase adherence. Participants receive PrEP medications from selected pharmacies, a strategy designed to improve PrEP access and enhance privacy/discretion. Additionally, participants in the intervention are awarded escalating gift card values for each successful refill collection at study pharmacies, aiming to incentivize continued PrEP use for effective HIV prevention. The intervention seeks to enhance convenience and motivate adherence through financial rewards.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control (Standard of care)
Description: For sex workers in the control group, PrEP refill pick-up will be available through CESHHAR's existing network of clinical sites. There is no gift card incentive and no pick-up at private pharmacies.
Study: NCT04915313

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Description: RIC is a non-invasive therapy which is performed by automated pneumatic cuffs placed on bilateral arms. The RIC protocol include five cycles of 5-min inflation to 200mmHg and 5-min deflation.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham remote ischemic conditioning (Sham-RIC)
Description: The Sham-RIC protocol include five cycles of 5-min inflation to 60 mmHg and 5-min deflation by placing automated pneumatic cuffs on bilateral arms.
Study: NCT05401201

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard oral hygiene self care
Description: Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self care.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard oral hygiene self care
Description: Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self care.
Study: NCT06577077

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Product CM9241GRU
Description: 01 tablet in the morning and 01 tablet in the evening for 14 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 01 tablet in the morning and 01 tablet in the evening for 14 days